gms | German Medical Science

71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21.06. - 24.06.2020

Fungal brain abscess – not longer a death sentence

Pilzabszesse des Gehirns – nicht länger ein Todesurteil

Meeting Abstract

  • presenting/speaker Nicole Lange - Technische Universität München, Neuropathologie, München, Deutschland
  • Ann-Kathrin Jörger - Technische Universität München, Neuropathologie, München, Deutschland
  • Arthur Wagner - Technische Universität München, Neuropathologie, München, Deutschland
  • Friederike Liesche - Technische Universität München, Neuropathologie, München, Deutschland
  • Nina Wantia - Technische Universität München, Neurochirurgie, München, Deutschland
  • Bernhard Meyer - Technische Universität München, Neurochirurgie, München, Deutschland
  • Jens Gempt - Technische Universität München, Neurochirurgie, München, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. sine loco [digital], 21.-24.06.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocP091

doi: 10.3205/20dgnc378, urn:nbn:de:0183-20dgnc3781

Published: June 26, 2020

© 2020 Lange et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Cerebral aspergillosis is a rare but severe and life threatening condition. The aim of this case series wa, to provide a modern cohort of patients with cerebral aspergillosis, assess the clinical characteristics and reveal the relevant aspects for future therapy for such a condition.

Methods: In a 10 years period from January 2009 to January 2019, we identified 10 patients (6 male, 4 female) who underwent surgery or frameless stereotactic drainage of a cerebral aspergilloma at our center. Patients and disease characteristics were recorded, including age, mortality, dates and types of surgical procedures, neurological symptoms and length and type of antifungal treatment, germ spectrum and immunosuppressive conditions were also assessed.

Results: The median age was 65 (range 45 to 83). We conducted 133 cranial surgeries in 100 patients due to cerebral brain abscess (BA) during that time, resulting in a percentage of 10% of aspergilloma within BAs in our patient sample. We performed 3.1 surgeries per patient followed by antifungal treatment for 6 months (=median) according to the microbiological findings. Regarding comorbidities, mean CCI at the time of admission was 5, representing an estimated 10-year survival of 21%. Six of 10 patients (60%) had conditions of immunosuppression, one suffered endocarditis after replacement of aortic valves. 4 patients showed associated frontobasal bone destruction, mycotic aneurysms or thromboses. Mean duration of hospital stay was 37 days. Mortality was much lower than in the literature. 60% of the patients died during the follow-up period. Outcome of the two immunocompetent patients was more favorable.

Conclusion: Cerebral aspergillosis is a rare, but still life threatening condition, which predominantly occurs in immunosuppressive conditions. Due to radical surgical removal of infected tissue and antifungal therapy for several months, mortality can be reduced dramatically.